Estrogen‐Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.1553
Abstract: The association between estrogen‐containing oral contraceptives and history of pregnancies with disease severity in women with polycystic liver disease (PLD) is unclear. We performed a cross‐sectional cohort study to assess this association by selecting female… read more here.
Keywords: containing oral; polycystic liver; estrogen containing; disease severity ... See more keywords
Risk of recurrence in women with venous thromboembolism related to estrogen‐containing contraceptives: Systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15661
Abstract: The risk of recurrence after a venous thromboembolism (VTE) related to estrogen‐containing contraceptives is a key driver to guide anticoagulant treatment decisions. read more here.
Keywords: venous thromboembolism; risk recurrence; containing contraceptives; related estrogen ... See more keywords
The Association Between Estrogen-Containing Oral Contraceptive Pills and Hypothyroidism
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Endocrinology"
DOI: 10.1155/ije/5978558
Abstract: Background: Hypothyroidism is an endocrine disorder that affects 10 times more females than males, with substantial health impacts. The role of estrogen-containing oral contraceptives (OCPs) in influencing thyroid function remains relatively underexplored. This study investigated… read more here.
Keywords: hypothyroidism; odds hypothyroidism; shbg levels; estrogen containing ... See more keywords